Republicans in congress are advocating for a restructuring of the National Institutes of Health (NIH) to remove its authority over “gain of function” research and halt such experiments until new regulations are implemented.
This proposal suggests that public trust in government health agencies has eroded. It could serve as a blueprint for a future Republican-led administration and Congress.
In the near term, this plan increases pressure on the NIH as it approaches a challenging fiscal 2025 budget cycle, following a recent pause in funding increases. The House Energy and Commerce Committee's proposal seeks to create a new oversight system for high-risk pathogen research, transferring authority from the NIH to an independent public entity that would review, approve, or reject these experiments and supervise their conduct.
The plan calls for a temporary suspension of gain of function research until proper monitoring measures are established. It also aims to prevent the NIH from conducting or supporting such research in countries identified as foreign adversaries.
It also proposes integrating national security or intelligence reviews into the NIH's grant approval process, enhancing reporting and conflict-of-interest policies, and imposing five-year term limits on NIH institute directors, implicitly criticizing long-serving officials like former NIAID director Anthony Fauci.
Even if the reorganization plan does not proceed, it keeps attention on gain of function research. This field, which involves increasing the transmissibility of viruses and other pathogens, is often linked to theories that COVID-19 originated from a lab leak. Critics are concerned about inadequate laboratory safety oversight.
The NIH is under intense scrutiny from a series of House investigations. A recent report by the committee's GOP staff accused the NIH of misrepresenting risky research on mpox (monkeypox) and denying its approval when questioned by Congress. The House's Select Subcommittee on the Coronavirus revealed that a senior Fauci aide used a personal email to evade government oversight and communicated secretly with the nonprofit EcoHealth Alliance, which funded studies on bat coronaviruses in China, placing it at the center of the debate over the pandemic's origins.
The ongoing partisan disputes over the pandemic response and recent bipartisan criticism of the NIH, evident during Fauci's recent testimony before Congress, suggest a challenging period ahead for the agency. House Republicans are expected to continue holding NIH oversight hearings.
The NIH's federal funding decreased this year after seven consecutive years of increases, and it may face further cuts as House Republicans aim to reduce overall health spending. A recent report from Raymond James projected that the NIH's final FY25 funding could range from $47.9 billion in an optimistic scenario to $44.25 billion in a pessimistic one. House appropriators are scheduled to begin marking up the primary health discretionary spending bill on June 27.
Read the draft plan here.
